Stuttgart - Delayed Quote EUR
ImmuPharma PLC (25I.SG)
0.0325
-0.0005
(-1.52%)
At close: May 2 at 3:13:39 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,364.4070
-1,364.4070
-2,347.0650
-4,833.1720
-3,329.4010
Investing Cash Flow
188.7620
188.7620
-77.4240
-50.2830
-569.2010
Financing Cash Flow
722.0960
722.0960
1,547.7300
702.0470
8,370.3540
End Cash Position
208.4810
208.4810
667.8130
1,649.3740
5,862.0570
Capital Expenditure
--
--
-106.0090
-50.9340
-360.2900
Issuance of Capital Stock
1,480.6830
1,480.6830
2,350.9090
3,550
8,000
Issuance of Debt
--
--
--
--
2,152.2520
Repayment of Debt
--
--
--
-722.9780
-836.6060
Free Cash Flow
-1,364.4070
-1,364.4070
-2,453.0740
-4,884.1060
-3,689.6910
12/31/2020 - 7/21/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
328.SG MeiraGTx Holdings PLC
6.45
+4.03%
BT3.BE Lineage Cell Therapeutics Inc
0.4320
+7.46%
PI3.DU Gubra AS
54.00
+9.27%
HQ1.MU Oruka Therapeutics Inc. R
9.10
0.00%
CLDWW Calidi Biotherapeutics, Inc.
0.0055
-15.38%
22UA.MU BioNTech SE
91.15
-0.16%
GNFTF Genfit S.A.
3.5400
0.00%
AYJ.HA Valneva SE
2.9200
+0.97%
BNTX.VI BioNTech SE
92.25
+1.26%